ADO (ASX) Ex ??? COO Tamara Mills

Originally posted by riverbrae ↑

Hi secondsight
OOPS

Chief Operations Officer

Company NameDE MOTU CORDIS

Dates EmployedFeb 2017 – Present

Employment Duration5 mos

LocationBrisbane, Australia
Chief Operations Officer at De Motu Cordis Pty. Ltd (DMC), a medtech startup commercially developing an advanced drug delivery system for critical care patients. The technology has the potential to significantly improve patient outcomes, reducing the long-term health costs of patients following cardiac arrest. Further products within the DMC portfolio leveraging the technology behind the critical care advanced drug delivery system include drug device combinations for improved treatment of hypoglycemia and anaphylaxis.

Co-Founder and CEO

Company NameGlucotek Inc

Dates EmployedMar 2017 – Present

Employment Duration4 mos

LocationBrisbane, Australia
Our mission is to make the management of gestational diabetes simple, non-invasive and easy, improving the lives of diabetic mothers and their babies.

Founder

Company NameFundamedtech

Dates EmployedMar 2015 – Present

Employment Duration2 yrs 4 mos

LocationMontreal, Canada Area
Fundamedtech is a niche medical technology start-up incubator specializing in complex medical device and digital health products.

While most health technology accelerators and incubators steer clear from ventures pursuing the development of complex medical technologies requiring pre-marketing authorization, this is our core focus.

Co Founder

Company NameSynaptecha

Dates EmployedJan 2016 – Present

Employment Duration1 yr 6 mos

LocationMontreal, Canada Area
Synaptecha is a medical technology startup developing smart beautifully designed medical devices to track and monitor patients with chronic illnesses

Founder

Company NameMSMx

Dates EmployedJan 2016 – Present

Employment Duration1 yr 6 mos

LocationMontreal, Canada Area
Today there is no simple effective method for diagnosing MS, there is no way of knowing upfront which treatment will be most effective for the patient and result in least side-effects, there is no quick effective means of monitoring response to treatment, treatment adherence and there is no means of being able to predict or prevent relapse, often resulting in hospital admission for treatment depending on severity. MSMx is developing a Diagnostic test with high sensitivity, specificity, strong negative and positive predictive value enabling early treatment of MS and prediction of treatment response in addition to a Wearable Integrated Digital health platform enabling real-time monitoring , trending and machine learning of personal and environmental factors correlated treatment, disease progression and relapse

Chief Operations Officer

Company NameAnteo Diagnostics

Dates EmployedJul 2016 – Feb 2017

Employment Duration7 mos

LocationAustralia
Led the operations and product commercialization for Anteo Diagnostics Limited (ASX: ADO), a global nanotechnology company developing and commercializing products for the life sciences, clinical diagnostics,medical device, energy, and bioseparations markets. The Anteo Group owns a patented nanochemistry surface engineering technology with high-value
commercial applications in protein binding and anti-body coupling, point of care devices, in-vivo medical devices, medical drug delivery, and batteries

Expand

Oops, must have tomatoes on my eyes. Or it is the heat, we have at the moment about 35 degree in Germany... ;-)
Thank's!

No.	Vol.	Price($)
4	1142321	1.9¢

No.

Vol.

Price($)

1142321

1.9¢

Price($)	Vol.	No.
2.0¢	339684	2

Price($)

Vol.

No.

2.0¢

339684

No.	Vol.	Price($)
4	1142321	0.019
10	1338162	0.018
5	807891	0.017
5	1629529	0.016
7	1203869	0.015

No.

Vol.

Price($)

1142321

0.019

1338162

0.018

807891

0.017

1629529

0.016

1203869

0.015

Price($)	Vol.	No.
0.020	339684	2
0.021	592746	5
0.022	505000	2
0.023	420000	2
0.024	164509	3

Price($)

Vol.

No.

0.020

339684

0.021

592746

0.022

505000

0.023

420000

0.024

164509

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $46.90M

Open	High	Low	Value	Volume
1.9¢	1.9¢	1.9¢	$23.42K	1.233M

Oops, must have tomatoes on my eyes. Or it is the heat, we have...

True North increases silver metal at QLD's Vero deposit by 20%

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Revolutionary inverter technology leads the clean energy charge

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Oops, must have tomatoes on my eyes. Or it is the heat, we have...

Top Stories

True North increases silver metal at QLD's Vero deposit by 20%

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

Revolutionary inverter technology leads the clean energy charge

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Bitcoin: Current State of Play & Where to Next | Swyftx

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Emerald & Azure score Digger & Dealer awards

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News